Core Viewpoint - *ST Jinbi (002762.SZ) expects a net profit attributable to shareholders of the listed company for 2025 to be between -190 million and -130 million yuan, with a net profit excluding non-recurring gains and losses projected to be between -120 million and -80 million yuan, and operating revenue estimated at 350 million to 380 million yuan [1] Group 1: Revenue Changes - The revenue change is attributed to the acquisition of Zhuhai Hanfei and Zhongshan Hanfei at the end of 2024, which is expected to contribute approximately 68 million yuan to operating revenue in 2025 [1] - In 2025, the company will continue to expand its online channels and extend its product line strategy from maternal and infant products to fast-moving consumer goods for families, driving revenue growth [1] Group 2: Profit Indicators - The change in profit indicators is primarily due to the continuous losses from the associated company Guangdong Hanfei Hospital Investment Co., Ltd., which will require the company to recognize corresponding investment losses and make provisions for long-term equity investment impairment in 2025 [1]

Core Viewpoint - *ST Jinbi (002762.SZ) expects a net profit attributable to shareholders of the listed company to be between -190 million and -130 million yuan for 2025, with a revenue forecast of 350 million to 380 million yuan [1] Group 1: Revenue Changes - The revenue change is attributed to the acquisition of Zhuhai Hanfei and Zhongshan Hanfei at the end of 2024, which is expected to contribute approximately 68 million yuan to revenue in 2025 [1] - The company plans to continue its product line extension strategy and expand online channels, transitioning from maternal and infant products to fast-moving consumer goods for families, which is anticipated to drive revenue growth [1] Group 2: Profit Indicators - The profit indicators are primarily affected by the ongoing losses from the associated company Guangdong Hanfei Hospital Investment Co., Ltd., leading to the need for the company to recognize corresponding investment losses and provision for long-term equity investment impairment in 2025 [1]